Aug. 8 at 3:24 PM
$LLY drops hard after strong Q2 — is this the dip to buy?
Solid earnings weren’t enough to offset weak obesity drug data, sending shares lower. But top-exposed ETFs like
$IHE,
$PPH,
$MEDX and
$MEDI could offer upside.
Find out what makes these ETFs worth a closer look 👉 https://www.zacks.com/stock/news/2684363/etfs-in-focus-on-eli-lillys-solid-q2-earnings-weak-obesity-data?cid=sm-stocktwits-2-2684363-teaser-6913&ADID=SYND_STOCKTWITS_TWEET_2_2684363_TEASER_6913